Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05658757 · ClinicalTrials.gov registry record · NA

Preliminary Effect of Food Processing and Sweeteners on Glycemic and Metabolic Measures

A NA study of Blood Pressure and Dietary Habits, sponsored by University of California, Irvine.

Completed
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT05658757 is a NA study of Blood Pressure and Dietary Habits that has completed, run by University of California, Irvine. The registered enrollment target is 15 participants, below the 287-participant average among 101 other Blood Pressure trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05658757, a NA study of Blood Pressure and Dietary Habits, has completed, sponsored by University of California, Irvine.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

The average adult in the US consumes over 1/3 of a cup of sugar each day, or nearly 300 calories worth, with the primary sources being from beverages, desserts and sweet snacks, candy, additions to beverages, and foods such as breakfast cereals. This is a risky health behavior, as high added sugar intake relates to higher risk of gaining weight, blood sugar disorders such as type 2 diabetes, plus heart disease and various cancers. Thus, high added sugar intake is problematic, and something in need of reducing. Therefore, the investigators are proposing to test how commercial foods sweetened with a new, FDA approved rare sugar with net zero calories (allulose), that is derived from dried fruits, brown sugar, and maple syrup may impact added sugar intake and usual blood sugar levels. The investigators are doing this by a randomized trial, in which the investigators will recruit participants with abnormal blood sugars (prediabetes or diabetes) or higher metabolic risk (bigger waist and elevated blood pressure or blood cholesterol) and ask them in random order to include foods in their usual dietary intake that are sweetened by regular sugars (regular sugar), foods that are sweetened by the zero calorie rare sugar allulose (low added sugar), or low added sugar intake by higher intake of fresh fruits and minimally processed and sweetened foods in place of usual sweetened foods. The investigators will measure their usual blood sugar levels for each of these 3 different 2- week periods with a blood glucose monitor, along with what they eat each of those periods, their blood pressure, and how the different dietary approaches impact how they feel.

Interventions

  • OTHER Regular sweetened commercial foods
  • OTHER Allulose sweetened commercial foods
  • OTHER Whole and minimally processed and sweetened foods

Study Locations (1)

California

  • University of California, Irvine - Irvine

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2022-11-09
Est. Completion 2023-04-19
Phase NA

Sponsor

University of California, Irvine

368 total trials

What the Registry Record Tells You About NCT05658757

The ClinicalTrials.gov registry entry for NCT05658757 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 287-participant average among 101 other Blood Pressure trials with a reported enrollment target (95% lower). The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Blood Pressure appearing as the primary indexed condition, and to 3 interventions - of which Regular sweetened commercial foods is the first listed.

NCT05658757 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05658757 about?

NCT05658757 is a clinical study titled "Preliminary Effect of Food Processing and Sweeteners on Glycemic and Metabolic Measures". The average adult in the US consumes over 1/3 of a cup of sugar each day, or nearly 300 calories worth, with the primary sources being from beverages, desserts and sweet snacks, candy, additions to beverages, and foods such as breakfast cereals. This is a risky health behavior, as high added sugar i...

What is the current status of trial NCT05658757?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2022-11-09. Estimated completion is 2023-04-19.

What conditions does trial NCT05658757 study?

This clinical trial studies the following conditions: Blood Pressure, Dietary Habits, Blood Sugar; High.

What interventions are being tested in trial NCT05658757?

The interventions under investigation include: Regular sweetened commercial foods (OTHER), Allulose sweetened commercial foods (OTHER), Whole and minimally processed and sweetened foods (OTHER).

Who is sponsoring clinical trial NCT05658757?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05658757 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Blood Pressure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.